Publication:
Molecular docking and molecular dynamics studies of SARS-CoV-2 inhibitors: Crocin, digitoxigenin, beta eudesmol and favipiravir: comparative study

Thumbnail Image
Date
2022
Authors
Mora, José R.
Cuesta, Sebastián A.
Belhassan, Assia
Salgado Morán, G.
Lakhlifi, Tahar
Bouachrine, Mohammed
Peña F., Carlos
Dra. Gerli-Candia, Lorena
Mendoza Huizar, Luis H.
Journal Title
Journal ISSN
Volume Title
Publisher
AMG Transcend Association
Research Projects
Organizational Units
Journal Issue
Abstract
In this study, Crocin, Digitoxigenin, Beta-Eudesmol, and Favipiravir were docked in the active site of SARS-CoV-2 main protease (PDB code: 6LU7). The docking study was followed by Molecular Dynamics simulation. The result indicates that Crocin and Digitoxigenin are the structures with the best affinity in the studied enzyme's binding site. Still, Molecular Dynamics simulation showed that Digitoxigenin is the molecule that fits better in the active site of the main protease. Therefore, this molecule could have a more potent antiviral treatment of COVID-19 than the other three studied compounds.
Description
Keywords
Beta-Eudesmol, Crocin, Digitoxigenin, Favipiravir, SARS-CoV-2
Citation